CH454147A - Verfahren zur Herstellung eines neuen Isoxazolderivates - Google Patents

Verfahren zur Herstellung eines neuen Isoxazolderivates

Info

Publication number
CH454147A
CH454147A CH530965A CH530965A CH454147A CH 454147 A CH454147 A CH 454147A CH 530965 A CH530965 A CH 530965A CH 530965 A CH530965 A CH 530965A CH 454147 A CH454147 A CH 454147A
Authority
CH
Switzerland
Prior art keywords
formula
isoxazole
hydroxy
acid
amino
Prior art date
Application number
CH530965A
Other languages
German (de)
English (en)
Inventor
R Dr Gagneux Andre
Franz Dr Haefliger
Eugster Conrad H Dr Prof
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CH1827667A priority Critical patent/CH450429A/de
Priority to CH405365A priority patent/CH454146A/de
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Priority to CH530965A priority patent/CH454147A/de
Priority to AT41066A priority patent/AT253505B/de
Priority to IL23592A priority patent/IL23592A/xx
Priority to GB22272/65A priority patent/GB1114116A/en
Priority to FR18944A priority patent/FR1440257A/fr
Priority to BE665249D priority patent/BE665249A/xx
Priority to NL6508403A priority patent/NL6508403A/xx
Priority to ES0315655A priority patent/ES315655A1/es
Priority to FR29813A priority patent/FR4592M/fr
Priority to DK453866A priority patent/DK111488B/da
Publication of CH454147A publication Critical patent/CH454147A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH530965A 1964-07-22 1965-04-15 Verfahren zur Herstellung eines neuen Isoxazolderivates CH454147A (de)

Priority Applications (12)

Application Number Priority Date Filing Date Title
CH1827667A CH450429A (de) 1964-07-22 1965-03-23 Verfahren zur Herstellung von a-Halogen-3-hydroxy-5-isoxazolessigsäure
CH405365A CH454146A (de) 1964-07-22 1965-03-23 Verfahren zur Herstellung des Ammoniumsalzes der neuen a-Amino-3-hydroxy-5-isoxazolessigsäure
CH530965A CH454147A (de) 1965-04-15 1965-04-15 Verfahren zur Herstellung eines neuen Isoxazolderivates
AT41066A AT253505B (de) 1965-04-15 1965-05-17 Verfahren zur Herstellung der neuen α-Amino-3-hydroxy-5-isoxazolessigsäure
IL23592A IL23592A (en) 1964-07-22 1965-05-24 Isoxazole derivative and a process for its production
GB22272/65A GB1114116A (en) 1964-07-22 1965-05-26 Isoxazole derivative and processes for its preparation
FR18944A FR1440257A (fr) 1964-07-22 1965-05-31 Nouveau dérivé de l'isoxazole et sa préparation
BE665249D BE665249A (da) 1964-07-22 1965-06-10
NL6508403A NL6508403A (da) 1964-07-22 1965-06-30
ES0315655A ES315655A1 (es) 1964-07-22 1965-07-05 Procedimiento para la preparacion de un nuevo derivado de isoxazol.
FR29813A FR4592M (da) 1964-07-22 1965-08-30
DK453866A DK111488B (da) 1965-04-15 1966-09-02 Fremgangsmåde til fremstilling af α-amino-3-hydroxy-5-isoxazoleddikesyre eller salte deraf.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH530965A CH454147A (de) 1965-04-15 1965-04-15 Verfahren zur Herstellung eines neuen Isoxazolderivates

Publications (1)

Publication Number Publication Date
CH454147A true CH454147A (de) 1968-04-15

Family

ID=4291422

Family Applications (1)

Application Number Title Priority Date Filing Date
CH530965A CH454147A (de) 1964-07-22 1965-04-15 Verfahren zur Herstellung eines neuen Isoxazolderivates

Country Status (3)

Country Link
AT (1) AT253505B (da)
CH (1) CH454147A (da)
DK (1) DK111488B (da)

Also Published As

Publication number Publication date
AT253505B (de) 1967-04-10
DK111488B (da) 1968-09-02

Similar Documents

Publication Publication Date Title
DE2610886C2 (da)
DE2305092C2 (da)
DE2461802A1 (de) Pyrazinderivate
DE2044172C3 (de) Pyrrolderivate, ein Verfahren zu ihrer Herstellung und Arzneimittel
EP0132811A1 (de) In 1-Stellung substituierte 4-Hydroxymethyl-pyrrolidinone, Verfahren zu ihrer Herstellung, pharmazeutische Zusammensetzungen und Zwischenprodukte
DE2542335A1 (de) Neue derivate des 5h-dibenz eckige klammer auf b,f eckige klammer zu azepins und verfahren zu ihrer herstellung
EP0086416A2 (de) Corynanthein-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE1618465C3 (de) Phenylessigsäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1695111B1 (de) Indolderivate
CH524612A (de) Verfahren zur Herstellung von neuen Imidazolderivaten
CH454147A (de) Verfahren zur Herstellung eines neuen Isoxazolderivates
DE2611118C2 (da)
DE1695298B2 (de) S-AcetamMo-e-methyl-e-n-propyl-striazolo eckige Klammer auf 4,3-a eckige Klammer zu pyrazin und Verfahren zu seiner Herstellung und Arzneimittel
DE2007700C2 (de) Substituierte o-Anilino-phenäthylalkohole, Verfahren zu ihrer Herstellung und therapeutische Präparate
DE2013256C (da)
DE2615129A1 (de) Tripeptide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2144641B2 (de) Phenylacethydroxamsäuren und Verfahren zu ihrer Herstellung
DE2610679C2 (de) Sulfinylgruppenhaltige Oximätherderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
AT253504B (de) Verfahren zur Herstellung der neuen α-Amino-3-hydroxy-5-isoxazolessigsäure
AT331217B (de) Verfahren zur herstellung von neuen aminobenzylaminen sowie deren saureadditionssalzen
DE2633890A1 (de) Neue 7-amino-6,7-dihydro- eckige klammer auf 5h eckige klammer zu -benzocyclohepten-derivate und deren salze, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
AT201783B (de) Verfahren zur Herstellung von neuen ätherartigen Derivaten der Tropanreihe
AT282593B (de) Verfahren zur herstellung von neuem racemischem oder optisch aktivem (1-2'-nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan und dessen salzen
AT278785B (de) Verfahren zur Herstellung von neuen Piperidinderivaten und ihren Salzen
DE2221281A1 (de) Pyrazolderivate und Verfahren zu ihrer Herstellung